Xiong et al. used OX-A gene-knocked rats and wild-type rats to develop a model of middle cerebral artery occlusion and found that OX-A could play an anti-inflammatory role in reducing cerebral infarction area and neuroprotection by inhibiting myeloperoxidase activity [41]. The gene discussed is MPO; the disease is cerebral artery occlusion.